AKT1 and melanoma: The observed therapeutic effects likely result from multitarget engagement within KEGG pathways-specifically targeting key nodes such as PI3K-AKT and MAPK-highlighting a potential mechanism for synergistic multipathway modulation in melanoma prevention and treatment.